Authors: TERHUNE SS COLEMAN KT SEKULOVICH R BURKE RL SPEAR PG

Citation: Ss. Terhune et al., LIMITED VARIABILITY OF GLYCOPROTEIN GENE-SEQUENCES AND NEUTRALIZING TARGETS IN HERPES-SIMPLEX VIRUS TYPE-2 ISOLATES AND STABILITY ON PASSAGE IN CELL-CULTURE, The Journal of infectious diseases, 178(1), 1998, pp. 8-15

Authors: STRAUS SE WALD A KOST RG MCKENZIE R LANGENBERG AGM HOHMAN P LEKSTROM J COX E NAKAMURA M SEKULOVICH R IZU A DEKKER C COREY L

Citation: Se. Straus et al., IMMUNOTHERAPY OF RECURRENT GENITAL HERPES WITH RECOMBINANT HERPES-SIMPLEX VIRUS TYPE-2 GLYCOPROTEIN-D AND GLYCOPROTEIN-B - RESULTS OF A PLACEBO-CONTROLLED VACCINE TRIAL, The Journal of infectious diseases, 176(5), 1997, pp. 1129-1134

Authors: PASS RF DULIEGE AM BOPPANA SB BRITT WJ GRANOFF DM SEKULOVICH R BURKE RL

Citation: Rf. Pass et al., IMMUNOGENICITY OF A RECOMBINANT CMV GB VACCINE, Pediatric research, 37(4), 1995, pp. 185-185

Authors: LANGENBERG AG BURKE RL ADAIR SF SEKULOVICH R TIGGES M DEKKER CL

Citation: Ag. Langenberg et al., A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX VIRUS TYPE-2 - SAFETY AND IMMUNOGENICITY (VOL 122, PG 889, 1995), Annals of internal medicine, 123(5), 1995, pp. 395-395

Authors: STRAUS SE COREY L BURKE RL SAVARESE B BARNUM G KRAUSE PR KOST RG MEIER JL SEKULOVICH R ADAIR SF DEKKER CL

Citation: Se. Straus et al., PLACEBO-CONTROLLED TRIAL OF VACCINATION WITH RECOMBINANT GLYCOPROTEIN-D OF HERPES-SIMPLEX VIRUS TYPE-2 FOR IMMUNOTHERAPY OF GENITAL HERPES, Lancet, 343(8911), 1994, pp. 1460-1463